SCHEMBL458218

SCHEMBL458218

O=C(O)c1ccc2c(c1)CC(Nc1ncc(-c3cccnc3)cn1)CO2

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 7/20 0.65
GBA1 P04062 1/20 0.47
HDAC6 Q9UBN7 5/20 0.46
HDAC1 Q13547 3/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
KMO O15229 1/20 0.44
MKNK1 Q9BUB5 1/20 0.43
MKNK2 Q9HBH9 1/20 0.43
SCN5A Q14524 2/20 0.42
SCN9A Q15858 2/20 0.42
KCNH2 Q12809 1/20 0.42
ROCK2 O75116 1/20 0.41
TBXAS1 P24557 1/20 0.40
ENPP2 Q13822 1/20 0.40
IP6K1 Q92551 1/20 0.39
IP6K3 Q96PC2 1/20 0.39
IP6K2 Q9UHH9 1/20 0.39
ABL1 P00519 1/20 0.39
BCR P11274 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL446862 0.90 HDAC8 (0.79) HDAC8GBA1HDAC6HDAC1HDAC7
SCHEMBL464363 0.79 HDAC8 (1.00) HDAC8HDAC6HDAC1HDAC7HDAC9
SCHEMBL464378 0.78 HDAC8 (0.79) HDAC8HDAC6HDAC1HDAC7HDAC9
SCHEMBL31346183 0.67 KMO (0.56) KMOMKNK1MKNK2IP6K1IP6K3
SCHEMBL5278014 0.66 TDP1 (0.48) HDAC8ROCK2
SCHEMBL27927241 0.64 TDP1 (0.55) ROCK2
SCHEMBL20565074 0.64 ENPP2 (0.54) HDAC6HDAC1ENPP2
SCHEMBL29771624 0.64 ENPP2 (0.54) HDAC6HDAC1ENPP2
SCHEMBL13015042 0.64 CYP1A2 (0.61) HDAC1MKNK1MKNK2ROCK2
SCHEMBL206541 0.64 KMO (1.00) KMOMKNK1MKNK2IP6K1IP6K3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2613775-B1 N-HYDROXY-BENZAMIDES FOR THE TREATMENT OF CANCER HOFFMANN LA ROCHE (CH) 2014-07-30 EP disclosed
EP-2613775-A1 NOVEL N-HYDROXY-BENZAMIDES FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-07-17 EP disclosed
WO-2012031993-A1 NOVEL N-HYDROXY-BENZAMIDES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-03-15 WO disclosed